In light that ERRα deficiency increases the susceptibility of mice to rapamycin-induced NAFLD (23) and impairs the reversal of fasting-induced NAFLD during refeeding (88), inducing ERRα activity appears more beneficial to treat and reverse the instilled disease. This evidence concerns the gene ESRRA and metabolic dysfunction-associated steatotic liver disease.